Table 2.
Severity of new vertebral fractures
Pre-treatment grade | (A) Eldecalcitol | Total | (B) Alfacalcidol | Total | ||||
---|---|---|---|---|---|---|---|---|
Final fracture grade | Final fracture grade | |||||||
Mild | Moderate | Severe | Mild | Moderate | Severe | |||
Normal (Grade 0) | 17 | 24 | 11 | 52 | 17 | 31 | 19 | 67 |
(26.6 %) | (37.5 %) | (17.2 %) | (81.3 %) | (21.3 %) | (38.8 %) | (23.8 %) | (83.8 %) | |
Mild (Grade 1) | – | 5 | 0 | 5 | – | 2 | 2 | 4 |
– | (7.8 %) | (0.0 %) | (7.8 %) | – | (2.5 %) | (2.5 %) | (5.0 %) | |
Moderate (Grade 2) | – | 1a | 6 | 7 | – | – | 9 | 9 |
– | (1.6 %) | (9.4 %) | (10.9 %) | – | – | (11.3 %) | (11.3 %) | |
Total | 17 | 30 | 17 | 64 | 17 | 33 | 30 | 80 |
(26.6 %) | (46.9 %) | (26.6 %) | (100 %) | (21.3 %) | (41.3 %) | (37.5 %) | (100 %) |
Data are number of patients
aA patient with incident fracture with vertebral height reduction of 15 % and ≥4 mm but without grade change